SITC Cancer Immunotherapy CONNECT

 

Register now for the 32nd Annual Meeting & Pre-Conference Programs

Visit the SITC 2017 Annual Meeting website for the latest information on the premier destination for scientific exchange, education and networking in the cancer immunotherapy field.

REGISTER Today

Non-Small Cell Lung Cancer Immunotherapy: Clinical Management

Complete this FREE online CME/CNE activity to learn more about immunotherapy for non-small cell lung cancer, then engage your patients in discussion today!

*Current as of August 2016

Earn Your Credit

sitc_log_white.png

Join the Discussion! Create a Cancer Immunotherapy CONNECT Account

Learn and share information in the new Cancer Immunotherapy CONNECT Open Forum! Follow a few easy steps to create a free CONNECT account, upload a profile photo and join the conversation.

CREATE A SITC CONNECT ACCOUNT

2017 Advances in Cancer Immunotherapy™ – San Francisco

Join us May 6 in San Francisco, CA for the first Advances in Cancer Immunotherapy™ series program of 2017! Learn basic immunology principles, the mechanisms and clinical applications of immunotherapy for disease states with FDA-approved treatments and more.

Register for San Francisco


 

FOCIS-SITC Cancer Immunity & Immunotherapy Course

June 14 • Hilton Chicago • Chicago, Illinois

This course will review tumor immunology as the foundation of cancer immunotherapy, emphasizing fundamental principles, recent clinical advances, current limitations and opportunities for furthering clinical progress.

Learn More

Clinical Advances in Cancer Immunotherapy Online Portal

In partnership with Medscape Oncology, SITC offers a robust online learning portal designed to provide clinical oncologists with free, CME-/CE-certified education in the immunotherapy field.

Learn More

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • Immunotherapy@Brisbane 2017 Register online before Friday April 21! Final Program Released EMBO KEYNOTE LECTURE Professor Sir Marc Feldmann Kennedy Institute of Rheumatology, University of Oxford, UK KEY SPEAKER Professor Shimon ...

  • Profile Picture

    Henry Hillman, a Great Pittsburgher, Passes

    This message was posted by a user wishing to remain anonymous Another Great Pittsburgher Dies - Philanthropist Henry Hillman led the renaissance of Pittsburgh's rebirth, a benefactor of the Hillman Cancer Center, an NCI Designated Cancer Center.  http://www.post-gazette.com/local/city/2017/04/14/Philanthropist-Henry-Hillman-dies/stories/201704140181

  • Published April 11, 2017, in JAMA are the United States Preventative Services Task Force new recommendations for the surveillance of Prostate Cancer.  The USPSTF recommends that the decision to have a DRE and prostate screening with PSA should be up ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More